14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:FPRX
Delisted

Five Prime Therapeutics Stock Price (Quote)

$38.00
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.00 $38.00 Friday, 27th May 2022 FPRX stock ended at $38.00. During the day the stock fluctuated 0% from a day low at $38.00 to a day high of $38.00.
90 days $38.00 $38.00
52 weeks $38.00 $38.00

Historical Five Prime Therapeutics prices

Date Open High Low Close Volume
Sep 17, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 16, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 15, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 14, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 13, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 10, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 09, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 08, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 07, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 03, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 02, 2021 $38.00 $38.00 $38.00 $38.00 0
Sep 01, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 31, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 30, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 27, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 26, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 25, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 24, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 23, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 20, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 19, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 18, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 17, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 16, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 13, 2021 $38.00 $38.00 $38.00 $38.00 0
Click to get the best stock tips daily for free!

About Five Prime Therapeutics

Five Prime Therapeutics Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes in the United States. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ia/Ib clinical trials for the treatment of various cancers in combination with nivolumab; and is in Phase I/II... FPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT